PMC:7445716 / 49533-49770
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T305","span":{"begin":174,"end":179},"obj":"Body_part"},{"id":"T306","span":{"begin":203,"end":210},"obj":"Body_part"}],"attributes":[{"id":"A305","pred":"fma_id","subj":"T305","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A306","pred":"fma_id","subj":"T306","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":" SARS-CoV-2 PCR NA NA IVIG 400 mg/kg (5 days) NA After 2 weeks from admission complete resolution except anosmia, ageusia\nGutiérrez-Ortiz et al. [23] RT-PCR Leucopenia (3100 cells/µl) NA Increased total protein (62 mg/dl), WBC: 2/μl (all"}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T505","span":{"begin":1,"end":9},"obj":"Disease"},{"id":"T506","span":{"begin":105,"end":112},"obj":"Disease"},{"id":"T507","span":{"begin":157,"end":167},"obj":"Disease"}],"attributes":[{"id":"A505","pred":"mondo_id","subj":"T505","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A506","pred":"mondo_id","subj":"T506","obj":"http://purl.obolibrary.org/obo/MONDO_0010528"},{"id":"A507","pred":"mondo_id","subj":"T507","obj":"http://purl.obolibrary.org/obo/MONDO_0003785"}],"text":" SARS-CoV-2 PCR NA NA IVIG 400 mg/kg (5 days) NA After 2 weeks from admission complete resolution except anosmia, ageusia\nGutiérrez-Ortiz et al. [23] RT-PCR Leucopenia (3100 cells/µl) NA Increased total protein (62 mg/dl), WBC: 2/μl (all"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T348","span":{"begin":174,"end":179},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":" SARS-CoV-2 PCR NA NA IVIG 400 mg/kg (5 days) NA After 2 weeks from admission complete resolution except anosmia, ageusia\nGutiérrez-Ortiz et al. [23] RT-PCR Leucopenia (3100 cells/µl) NA Increased total protein (62 mg/dl), WBC: 2/μl (all"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T343","span":{"begin":16,"end":18},"obj":"Chemical"},{"id":"T344","span":{"begin":19,"end":21},"obj":"Chemical"},{"id":"T345","span":{"begin":46,"end":48},"obj":"Chemical"},{"id":"T346","span":{"begin":184,"end":186},"obj":"Chemical"},{"id":"T347","span":{"begin":203,"end":210},"obj":"Chemical"}],"attributes":[{"id":"A343","pred":"chebi_id","subj":"T343","obj":"http://purl.obolibrary.org/obo/CHEBI_33696"},{"id":"A344","pred":"chebi_id","subj":"T344","obj":"http://purl.obolibrary.org/obo/CHEBI_33696"},{"id":"A345","pred":"chebi_id","subj":"T345","obj":"http://purl.obolibrary.org/obo/CHEBI_33696"},{"id":"A346","pred":"chebi_id","subj":"T346","obj":"http://purl.obolibrary.org/obo/CHEBI_33696"},{"id":"A347","pred":"chebi_id","subj":"T347","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":" SARS-CoV-2 PCR NA NA IVIG 400 mg/kg (5 days) NA After 2 weeks from admission complete resolution except anosmia, ageusia\nGutiérrez-Ortiz et al. [23] RT-PCR Leucopenia (3100 cells/µl) NA Increased total protein (62 mg/dl), WBC: 2/μl (all"}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"711","span":{"begin":229,"end":231},"obj":"Gene"},{"id":"747","span":{"begin":0,"end":10},"obj":"Species"},{"id":"905","span":{"begin":104,"end":111},"obj":"Disease"},{"id":"906","span":{"begin":113,"end":120},"obj":"Disease"},{"id":"907","span":{"begin":156,"end":166},"obj":"Disease"}],"attributes":[{"id":"A711","pred":"tao:has_database_id","subj":"711","obj":"Gene:4591"},{"id":"A747","pred":"tao:has_database_id","subj":"747","obj":"Tax:2697049"},{"id":"A905","pred":"tao:has_database_id","subj":"905","obj":"MESH:D000857"},{"id":"A906","pred":"tao:has_database_id","subj":"906","obj":"MESH:D000370"},{"id":"A907","pred":"tao:has_database_id","subj":"907","obj":"MESH:C536227"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" SARS-CoV-2 PCR NA NA IVIG 400 mg/kg (5 days) NA After 2 weeks from admission complete resolution except anosmia, ageusia\nGutiérrez-Ortiz et al. [23] RT-PCR Leucopenia (3100 cells/µl) NA Increased total protein (62 mg/dl), WBC: 2/μl (all"}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T271","span":{"begin":122,"end":227},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" SARS-CoV-2 PCR NA NA IVIG 400 mg/kg (5 days) NA After 2 weeks from admission complete resolution except anosmia, ageusia\nGutiérrez-Ortiz et al. [23] RT-PCR Leucopenia (3100 cells/µl) NA Increased total protein (62 mg/dl), WBC: 2/μl (all"}
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T670","span":{"begin":105,"end":112},"obj":"Phenotype"},{"id":"T671","span":{"begin":114,"end":121},"obj":"Phenotype"}],"attributes":[{"id":"A670","pred":"hp_id","subj":"T670","obj":"http://purl.obolibrary.org/obo/HP_0000458"},{"id":"A671","pred":"hp_id","subj":"T671","obj":"http://purl.obolibrary.org/obo/HP_0041051"}],"text":" SARS-CoV-2 PCR NA NA IVIG 400 mg/kg (5 days) NA After 2 weeks from admission complete resolution except anosmia, ageusia\nGutiérrez-Ortiz et al. [23] RT-PCR Leucopenia (3100 cells/µl) NA Increased total protein (62 mg/dl), WBC: 2/μl (all"}
LitCovid-PMC-OGER-BB
{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T552","span":{"begin":1,"end":11},"obj":"SP_7"}],"text":" SARS-CoV-2 PCR NA NA IVIG 400 mg/kg (5 days) NA After 2 weeks from admission complete resolution except anosmia, ageusia\nGutiérrez-Ortiz et al. [23] RT-PCR Leucopenia (3100 cells/µl) NA Increased total protein (62 mg/dl), WBC: 2/μl (all"}
2_test
{"project":"2_test","denotations":[{"id":"32840686-32303650-63205768","span":{"begin":145,"end":147},"obj":"32303650"}],"text":" SARS-CoV-2 PCR NA NA IVIG 400 mg/kg (5 days) NA After 2 weeks from admission complete resolution except anosmia, ageusia\nGutiérrez-Ortiz et al. [23] RT-PCR Leucopenia (3100 cells/µl) NA Increased total protein (62 mg/dl), WBC: 2/μl (all"}